Hypertrophic Cardiomyopathy pre-screening in college athletes — Presentation Detail — Celebration of Scholars

Instructions

Student presentations must have a faculty sponsor.

Abstracts must include a title and a description of the research, scholarship, or creative work. The description should be 150-225 words in length and constructed in a format or style appropriate for the presenter’s discipline.

The following points should be addressed within the selected format or style for the abstract:

A clear statement of the problem or question you pursued, or the scholarly goal or creative theme achieved in your work.
A brief comment about the significance or uniqueness of the work.
A clear description of the methods used to achieve the purpose or goals for the work.
A statement of the conclusions, results, outcomes, or recommendations, or if the work is still in progress, the results you expect to report at the event.

Presenter photographs should be head and shoulder shots comparable to passport photos.

Additional Information

More information is available at carthage.edu/celebration-scholars/. The following are members of the Research, Scholarship, and Creativity Committee who are eager to listen to ideas and answer questions:

Jun Wang
Kim Instenes
John Kirk
Nora Nickels
Andrew Pustina
James Ripley

Hypertrophic Cardiomyopathy pre-screening in college athletes

Name: Kelsey Welch
Major: Athletic Training
Hometown: Virginia Beach, VA
Faculty Sponsor: Ashley Greenwood ’14
Other Sponsors: Jensen, Laurie
Type of research: Independent research

Abstract

Hypertrophic Cardiomyopathy is a shocking occurrence health care providers in sports medicine potentially encounter. This event occurs in over 80% of asymptomatic patients under the age of thirty years old. Sudden Cardiac Arrest (SCA) can occur due to genetics, left ventricle wall thickness, or Hypertrophic Cardiomyopathy (HCM). According to the American Heart Association (AHA), there is no recommendation for pre-screening tools besides an intensive patient history and physical examination for HCM. However, this method of screening can lack sensitivity and specificity to identify HCM. This analysis asks, in college students, would pre-participation screening for hypertrophic cardiomyopathy reduce the risk of death in athletes compared to no use of a pre-screen tool? What is the cost analysis for universities to adopt the pre-screen tools recommended for use by researchers?

The articles were found through various medical research channels such as the National Institutes of Health, Pubmed, Cochrane Library, and Medline Plus. The key words used were HCM, SCA, college, athletes, cost, test(-ing), Electrocardiogram, pre-screen, and tool. Over fifty articles were examined from the research but only fifteen were used.

Collectively, the articles presented that there is a need for more use of a pre-screen tool, such as an ECG. The research found that the cost of pre-screening tools outweighs the benefits for identifying student-athletes with HCM.

Poster file